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Chapter 1: Introduction  
Living organisms are frequently exposed to oxidative stress and xenobiotic compounds (drugs or 
environmental compounds that are not native to a given biological system) that can be toxic or 
carcinogenic if not detoxified.  Correlational studies have indicated that exposure to environmental 
toxins or oxidative stress can result in epigenetic modifications (i.e. remodeling the chromatin to 
express or repress different genes) which can have important implications for the development of 
an organism (Marsit 2015). For example, arsenic is a metalloid compound that is often found in 
groundwater and industrial plants. Long term exposure to arsenic has been found to correlate with 
alterations in histone modification (Chervona et al. 2012) and DNA methylation (Pilsner et al. 2007, 
2012). These epigenetic alterations may be responsible for the toxic effects of arsenic, but the 
mechanisms that mediate these epigenetic alterations remain unknown (Marsit 2015).  
The Nrf2/Keap1 signaling pathway is one detoxification mechanism employed by many organisms 
(Itoh, Ishii, et al. 1999). Regulation of gene expression via the Nrf2/Keap1 pathway provides a 
mechanism for both (1) short-term response to oxidative stress and xenobiotic factors (Itoh, Ishii, 
et al. 1999) and (2) regulation of normal development and other cellular processes (Deng and 
Kerppola 2013). Although the short-term xenobiotic response pathway is well understood, the 
longer-term effects of xenobiotics on development at the molecular level remain unknown. 
Elucidating the mechanisms by which Nrf2/Keap1 signaling regulates normal development is the 
first step towards understanding the mechanisms by which xenobiotics affect development. 
Recently, it was found that Drosophila Nrf2 and Keap1 (CncC and dKeap1) regulate normal 
development by regulating ecdysone biosynthesis and response (Deng and Kerppola 2013). The 
goal of this research was to elucidate other mechanisms by which Nrf2 and Keap1 might regulate 
normal development. Since epigenetic regulation is important in development, I investigated 
whether Nrf2 and Keap1 regulate chromatin structure. 
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Understanding the developmental and epigenetic roles of the Nrf2/Keap1 pathway can have several 
important implications. First, regulating epigenetics may represent another mechanism by which 
the Nrf2/Keap1 pathway can regulate development. Second, since Nrf2 and Keap1 regulate toxin 
response, epigenetics, and normal development the Nrf2/Keap1 pathway may mediate the effects 
of toxins on epigenetic status and/or the effects of toxins on development. Finally, elucidating the 
functions of Nrf2 and Keap1 in normal development can further our understanding of the complex 
role of Nrf2/Keap1 in human disease and potentially lead to the development of therapies that target 
these genes in the treatments of diseases and developmental disorders. 
Response to Xenobiotic Factors  
Nrf2 is a transcription factor that activates the 
transcription of genes encoding detoxification and 
antioxidant genes (which encode many 
cytochrome P450 enzymes) in response to 
xenobiotic compounds and oxidative stress, 
respectively. Under non-stress conditions (Figure 
1A), cytoplasmic Nrf2 is bound by Keap1, which 
targets Nrf2 for ubiquitination and subsequent degradation (Furukawa and Xiong 2005). This 
degradation of Nrf2 prohibits Nrf2 from accumulating in the nucleus, thereby prohibiting Nrf2 
from activating xenobiotic response genes. When xenobiotic factors or oxidative stress is present 
(Figure 1B), the Keap1-Nrf2 interaction is disrupted, thereby allowing Nrf2 to enter the nucleus 
and activate xenobiotic response genes (Slocum and Kensler 2011). Nrf2 knockout mice are 
viable but they are more sensitive to chemical carcinogens and are more susceptible to diseases 
caused by (or aggravated by) oxidative stress (e.g. cancer, inflammatory diseases, and 
neurodegenerative diseases such as Parkinson’s disease) (Burton, Kensler, and Guilarte 2006; 
Hayes and Mcmahon 2009; Osburn and Kensler 2008). 
Nrf2 
• Nuclear factor erythroid 2-
related factor 2 
• bZIP family transcription factor 
• bZIP domain is the DNA binding 
domain 
• 605 amino acids 
• Localized to 2nd chromosome, in 
mice 
• ETGE and DLG domains (in 
Nrf2) are the binding sites for 
Keap1 
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Figure 1. Xenobiotic Response. (A) Under non-stress conditions, Keap1 binds to Nrf2 in the 
cytoplasm and targets it for ubiquitination and subsequent degradation. This inhibits Nrf2 from 
activating expression of xenobiotic response genes. (B) Xenobiotic factors, however, disrupt the 
binding of Keap1 to Nrf2. This frees Nrf2 to move to the nucleus and activate transcription of 
xenobiotic response genes. 
CncC and dKeap1 are the Drosophila homologs of Nrf2 and Keap1, respectively 
CncC is the Drosophila homolog of Nrf2 and they are largely conserved at both the molecular and 
functional level. Both contain a bZIP domain for DNA binding and the N-terminal ETGE and DLG 
motifs for Keap1 binding (Sykiotis and Bohmann 2008). They also have conserved functions in 
xenobiotic response. However, while Nrf2 knockout mice are viable, CncC knockout flies die as 
larvae. This may be because mammals have three Nrf family members (Nrf1, Nrf2, and Nrf3) and 
Nrf1 and Nrf3 can partially compensate for the loss of Nrf2. However, Nrf2 and Nrf3 cannot 
compensate for the loss of Nrf1 and Nrf1 knockout mice die early in development. In Drosophila, 
CncC performs both the 
functions of Nrf2 
(antioxidant response) and 
Nrf1 (regulation of 
proteasomal activity) 
(Pitoniak and Bohmann 
2015). Like Nrf2, CncC 
functions in xenobiotic 
and oxidative stress 
CncC 
• cap ‘n’ collar, isoform C 
• bZIP family transcription factor 
• 1383 amino acids 
• 101 kDa 
• Localized to 3rd chromosome, region 94E in Drosophila 
(Mohler et al. 1991) 
dKeap1 
• Drosophila Kelch-like ECH-Associated Protein 1 
• Kelch family protein (Itoh, Wakabayashi, et al. 1999) 
• 776 amino acids 
• 87 kDa 
• Localized to 3rd chromosome 
• Domains: 
o CTD – required for dKeap1 binding to chromatin 
o BTB Domain – CuI3 binding/Dimerization 
o DC/Kelch Domain – CncC binding 
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response and is regulated by dKeap1 (the Drosophila homolog of Keap1). Mammalian Keap1 and 
Drosophila Keap1 both contain a BTB dimerization domain as well a Kelch domain that functions 
as an Nrf2/CncC binding site (Sykiotis and Bohmann 2008). Both dKeap1 knockdown and 
exposure of flies to xenobiotic compounds will increase the activity of CncC, thereby increasing 
the transcription of xenobiotic response genes. Knockout of Keap1 in mice and knockout of dKeap1 
in Drosophila both result in an early lethal phenotype – Keap1 knockout mice die within 3 weeks 
of birth and dKeap1 knockout Drosophila die as larvae. 
Regulation of Development by CncC and dKeap1 
Nrf2 and Keap1 have also been found to play important roles in the regulation of development in 
mice and Drosophila. In mice, Nrf2 and Keap1 regulate developmental genes involved in 
adipogenesis (Kim et al. 2018) as well as genes involved in regulating neuronal stem cell 
differentiation (Khacho et al. 2016). In Drosophila, CncC and dKeap1 play an important role in 
metamorphosis (Deng and Kerppola 2013). The Drosophila life cycle involves a 1-day embryo 
stage followed by three larval stages, during which the larvae grow. The first two larval stages (1st 
instar and 2nd instar) each last approximately 1 day while the 3rd instar larval stage lasts 
approximately 2-3 days. The larvae then enter the pupa stage which lasts for 3.5 – 4.5 days before 
the fly ecloses as an adult (Ong et al. 2015). Metamorphosis is regulated by several hormones 
including ecdysone (the active form of ecdysone is 20-hydroxyecdysone, 20E) and Juvenile 
hormone (JH). Juvenile hormone represses metamorphosis, whereas 20E promotes molting. When 
both JH and 20E are present, the insect will molt to the next larval instar stage. When only 20E is 
present, the insect will undergo metamorphosis to the adult stage. While dKeap1 acts 
antagonistically on CncC to inhibit transcription of xenobiotic response genes, dKeap1 acts in 
concert with CncC to promote metamorphosis. To promote metamorphosis, CncC and dKeap1 
activate expression of juvenile hormone epoxide hydrolases, which degrade juvenile hormone in 
the salivary glands (Sun et al. 2017). Within the prothoracic gland, CncC and dKeap1 bind 
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cooperatively to the chromatin to activate ecdysone biosynthetic genes (Deng and Kerppola 2013; 
Figure 2). Once ecdysone has been synthesized, it is secreted to the hemolymph (the insect 
equivalent of blood) and transported to the salivary glands and other peripheral tissues where it is 
converted to 20-hydroxyecdysone (20E) (Ono 2014). Within the salivary glands, 20E enters the 
nucleus, binds to its receptor EcR, and activates the expression of ecdysone response genes. CncC 
and dKeap1 also localize to ecdysone puffs and activate ecdysone-response genes  (Deng and 
Kerppola 2013). 
 
Figure 2. CncC and dKeap1 bind to chromatin at ecdysone-regulated early puffs. In wild 
type larval salivary glands, CncC and dKeap1(yellow) bind to many loci on polytene 
chromosomes (blue). These loci include both early ecdysone-regulated puffs (labeled in white) as 
well as non-puff regions. The scale bar is 10m. This figure was originally published in (Deng 
and Kerppola 2013). 
Research goals and hypotheses 
Given the importance of epigenetics in development (Boland, Nazor, and Loring 2014) and the 
evidence that CncC and dKeap1 bind to chromatin (Deng and Kerppola 2013, 2014), the goal of 
this research was to investigate whether epigenetics may be a novel mechanism by which CncC 
and dKeap1 may regulate development. Specifically, this research aimed to determine whether 
CncC and dKeap1 regulate chromatin structure. Previous studies showed that CncC and dKeap1 
localize to many decondensed chromatin loci (Deng and Kerppola 2013). However, we did not 
know whether CncC and/or dKeap1 promoted the opening and/or maintenance of open chromatin 
Deng and Kerppola, 2013 PLOS Genetics 
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structure or if these proteins just bound to chromatin regions once they were de-condensed. Three 
preliminary studies indicated that CncC and dKeap1 may play a role in chromatin de-
condensation. First, CncC overexpression resulted in the de-condensation of the chromatin in 
telomere regions. Second, somatic knockout of dKeap1 in the salivary glands resulted in cells 
with more condensed polytene chromosomes compared to control cells. Third, the polytene 
chromosomes of dKeap1-ΔCTD truncation flies (ΔCTD is required for dKeap1 to bind to 
chromatin) had more condensed arms (all three of these are based on unpublished data from the 
Deng Lab). Two additional studies suggested that it is likely that CncC and dKeap1 may act 
cooperatively to regulate developmental genes. First, both CncC and dKeap1 bind to and activate 
ecdysone response genes (Deng and Kerppola 2013). Second, for some xenobiotic compounds, 
dKeap1-CncC complexes are necessary to activate transcription of response genes (Deng and 
Kerppola 2014). Thus, we hypothesized that dKeap1 and CncC function cooperatively to open 
the chromatin.  
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Chapter 2: Regulation of Position Effect Variegation at Pericentric 
Heterochromatin by Drosophila Keap1-Nrf2 Xenobiotic Response 
Factors 
Note: This chapter was previously published as:  
Carlson J., Swisse T., Smith C., Deng, H. Regulation of position effect variegation at pericentric 
heterochromatin by Drosophila Keap1-Nrf2 xenobiotic response factors. Genesis. 2019; 
57:e23290. 
Introduction 
Epigenetic modifications are thought to be important for mediating long-term developmental 
adaptations to constitutive changes in the environment.  Environmental epigenetic studies have 
revealed broad influences of environmental toxins on human epigenomes (Marsit 2015).  
However, the molecular mechanisms that mediate these influences are less understood.  
Elucidating the roles of stress response factors in epigenetic regulation will provide insights into 
the mechanisms that mediate the effects of environmental stimuli on development and human 
health.  
Keap1-Nrf2 stress response signaling is an essential pathway that protects cells from both 
endogenous reactive oxygen species and foreign toxic chemicals (xenobiotics) (Kensler, 
Wakabayashi, and Biswal 2007).  Nrf2 (NF-E2-Related Factor 2) is a bZIP family transcription 
factor that can bind to and activate a cassette of genes that encode antioxidant and detoxifying 
enzymes (Malhotra et al. 2010; Zhang 2006).  Keap1 (kelch-like ECH-associated protein 1) is a 
Kelch family protein that can interact with Nrf2 in the cytoplasm and induce Nrf2 ubiquitination 
and degradation (Itoh et al. 1999; McMahon et al. 2006).   Selective modifications of cysteine 
residues on Keap1 by oxidative and xenobiotic compounds disrupt the Keap1-Nrf2 interaction, 
resulting in the nuclear accumulation of Nrf2 and the activation of detoxifying genes (Eggler et 
al. 2005).  Mis-regulations of Keap1 and Nrf2 are associated with many diseases, including 
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cancer, neurodegeneration, and cardiovascular dysfunctions (Sykiotis and Bohmann 2010; 
Taguchi, Motohashi, and Yamamoto 2011).  
Recent studies in mice and Drosophila have revealed that Keap1-Nrf2 can regulate 
developmental genes and programs independent of oxidative/xenobiotic responses.  Drosophila 
dKeap1 and CncC (cap-n-collar C) proteins (the homologs of Keap1 and Nrf2, respectively) 
control metamorphosis through transcriptional regulation of ecdysone signaling (Deng and 
Kerppola 2013).  In mice, Nrf2 binds to and activates genes involved in adipogenesis and lipid 
metabolism in specific tissues (Huang et al. 2010; Pi et al. 2010).  Nrf2 can also promote cell 
proliferation through activation of genes that encode glucose metabolic enzymes (Mitsuishi et al. 
2012).  It is thought that the multiple developmental functions of Keap1 and Nrf2 account for at 
least some of their complicated roles in pathogeneses.  
Our previous studies in Drosophila have indicated that the mechanism by which dKeap1 and 
CncC regulate developmental genes is different from the established mechanism according to 
which Keap1-Nrf2 controls detoxifying genes.  Interestingly, dKeap1 can directly bind to 
chromatin and function as a transcriptional coactivator with CncC (Deng and Kerppola 2014).  
Both dKeap1 and CncC occupy ecdysone-response early puffs on polytene chromosomes and 
activate ecdysone-induced genes located at these puffs (Deng and Kerppola 2013).  The specific 
localization of dKeap1 and CncC at the polytene chromosome puffs, which represent highly de-
condensed chromatin regions, indicate a potential role for dKeap1 and CncC in chromatin 
remodeling.  
In this study, we employed position effect variegation (PEV) assays to examine the effects of 
cncC and dKeap1 mutants on the PEV expression of alleles at euchromatin/heterochromatin 
borders.  Surprisingly, both cncC and dKeap1 loss-of-function mutations suppress the 
variegations of wm4 and SbV pericentric PEV alleles.  Moreover, depletion of CncC or dKeap1 
reduces the level of the heterochromatin marker H3K9me2.  These results suggest that CncC and 
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dKeap1 might play positive roles in the establishment or maintenance of pericentric 
heterochromatin.  
Results and Discussion 
To determine the potential roles of CncC and dKeap1 in chromatin remodeling, we examined the 
effects of their loss-of-function mutations on the PEV of the wm4 allele.  The In(1)wm4 X 
chromosome contains an inversion that relocates the euchromatic white gene to the pericentric 
region (Schultz 1936).  Spreading of pericentric heterochromatin to the wm4 allele results in 
somatic variegation of white gene expression, causing white and red ommatidia in the compound 
eyes of adult flies (Elgin and Reuter 2013).  Genetic studies of this PEV allele suggest that 
depletion of heterochromatin factors can reduce the spreading of heterochromatin, therefore 
suppressing the variegation of wm4 expression (Su(var)) and increasing red ommatidia.  In 
contrast, depletion of euchromatic factors is predicted to increase the spreading of 
heterochromatin at the wm4 locus, thus enhancing the variegation (E(var)) and increasing white 
ommatidia (Elgin and Reuter 2013).  The loss-of-function alleles of cncC and dKeap1 are 
homozygous lethal at an early larval stage (Sykiotis and Bohmann 2008; Veraksa et al. 2000).  
We performed the PEV assay by introducing heterozygous mutations of cncCk6 and dKeap1036 
into the wm4 background.  Surprisingly, both cnck6/+ and dKeap1036/+ heterozygous mutants had 
significantly suppressed variegation of wm4, represented by the observation of more flies 
containing a higher percentage of red ommatidia (Figure 3).  The Su(var) effects were observed 
in both male and female populations, although females showed stronger suppression.  These 
results suggest that reduction of either CncC or dKeap1 causes a decrease of heterochromatic 
silencing at the wm4 locus.   
Given that Keap1/dKeap1 act as Nrf2/CncC inhibitors (Sykiotis and Bohmann 2008; Taguchi et 
al. 2011), we tested whether reducing dKeap1 can antagonize the PEV effect of CncC depletion 
by introducing a cncK6/+,dKeap1036/+ double heterozygous mutant into the wm4 background.  
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Combinatory reduction of dKeap1 and CncC enhanced PEV suppression more than CncC 
depletion alone in both females and males, suggesting that dKeap1 and CncC have an additive 
effect when regulating wm4 PEV (Figure 3).      
To exclude the possibility that unknown mutations in the cncCk6 and dKeap1036 flies caused the 
observed PEV effects, we examined other cncC and dKeap1 mutations that are generated 
separately in different genetic backgrounds.  Fly lines containing cncK22 and dKeap1EY5 alleles 
have red eyes and cannot be used for wm4 PEV assay.  Instead, we tested the effects of the cncK22 
and dKeap1EY5 alleles on the PEV of the SbV locus (Figure 4).  The dominant Sb gene gives rise 
to shorter and thicker bristles.  The T(2:3)SbV rearrangement results in pericentric localization of 
Sb, leading to the partial silencing of Sb by heterochromatin spreading and hence, the restoration 
of wild-type size of some scutellar bristles (Sinclair, Lloyd, and Grigliatti 1989).  We genetically 
combined SbV with cncK22, cncK6, dKeap1EY5, or dKeap1036 heterozygous mutations as well as 
relevant cncC/dKeap1 double heterozygous mutants.  All of the mutants had an increased number 
of short bristles in the scutellar region, indicating significant suppression of SbV PEV (Figure 4).  
These results further support the Su(var) effects of cncC and dKeap1 loss-of-function mutations 
on PEV alleles at the pericentric heterochromatic loci. 
 
Figure 3.  Regulation of wm4 PEV by cncC 
and dKeap1 loss-of-function mutations. 
Images: Examples of the degree of PEV in the 
eyes of wild-type (wt), cncK6/+, dKeap1036/+, 
and cncK6/+,dKeap1036/+ flies in the wm4 
background.  Histograms: Distribution of the 
percentage of 5 groups categorized by the 
portion of red ommatidia in flies with 
genotypes labeled below columns.  For each 
genotype, at least 100 flies were counted.  
Females and males were counted separately.  
Introduction of cncC and dKeap1 loss-of-
function alleles increased the number of flies 
with more red ommatidia, suggesting that 
reducing CncC or dKeap1 suppresses the 
variegation at the wm4 locus. 
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To determine if CncC and dKeap1 regulate PEV at other heterochromatic loci, we examined the 
effects of the cncK6/+ and dKeap1036/+ mutations and the cncK6/+,dKeap1036/+ double mutant on a 
PEV locus that is not in the pericentric region.  The 39C-5 line was generated through the 
insertion of a P-element containing a hsp70-white reporter gene into the telomeric area of 
chromosome 2L, which causes the variegation of white reporter expression (Wallrath and Elgin 
1995).  Introduction of cncK6/+ or dKeap1036/+ caused no significant effect on 39C-5 PEV.  
However, moderate suppression of 39C-5 PEV was observed in the females of the 
cncK6/+,dKeap1036/+ double mutant.  We speculate that CncC and dKeap1 likely control PEV at 
telomeric heterochromatin, but the effects were too weak to be detected in the heterozygous 
mutations, and only the additive effects of the cncC/dKeap1 double mutant made the PEV effect 
visible in our experiment.  The effects of cncC and dKeap1 mutations on PEV at telomeric and 
intercalary heterochromatin regions remain to be fully characterized. 
The observation that cncC and dKeap1 loss-of-function mutations act as suppressors of PEV at 
pericentric loci suggests that CncC and dKeap1 could facilitate heterochromatin formation.  To 
test this hypothesis, we examined the effect of CncC or dKeap1 depletion on the level of the 
Figure 4.  Regulation of SbV PEV by cncC 
and dKeap1 loss-of-function mutations. 
Images: Examples of the degree of PEV in the 
scutellar regions of wild-type (wt), cncK22/+, 
dKeap1EY5/+, and cncK22/+,dKeap1EY5/+ flies in 
the SbV background.  Examples of normal and 
stubble bristles are labeled by arrows and arrow 
heads respectively.  Histograms: Average 
numbers of stubble bristles among the 8 
scutellar bristles were counted in flies with 
genotypes listed below columns.  For each 
genotype, the standard deviation was calculated 
based on 200 flies that were counted.  The mean 
values that differ from wild-type at 95% 
confidence level (P<0.05) are indicated by an 
asterisk.  Introduction of cncC and dKeap1 loss-
of-function alleles increased the number of 
stubble bristles, suggesting that reducing CncC 
or dKeap1 suppresses the variegation at the SbV 
locus.   
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major heterochromatin marker histone H3K9me2 (Ebert et al. 2004).  Using western blotting, we 
detected and quantified the levels of H3K9me2 in embryos of cncK22 or dKeap1EY5 homozygous 
null mutations and in the heterozygous embryos used as controls (Figure 5A).  The levels of 
H3K9me2 significantly decreased in both cncC and dKeap1 null embryos, suggesting that both 
CncC and dKeap1 are required for the maintenance of a normal H3K9me2 level. 
Su(var)3-9 histone methytransferase and Heterochromatin Protein 1 (HP1a; encoded by the 
Su(var)205 gene) are the key factors that promote heterochromatin formation in Drosophila 
(James and Elgin 1986; Schotta et al. 2002; Tschiersch et al. 1994).  Given that CncC targets 
numerous genes (Misra et al. 2011), it is possible that CncC and dKeap1 regulate heterochromatin 
through controlling Su(var)3-9 or HP1a at the transcriptional level.  To assess this possibility, we 
examined expression levels of the Su(var)3-9 and Su(var)205 genes when CncC and dKeap1 
were knocked out in embryos or were RNAi-knocked down in salivary glands (Figure 5B).  No 
significant changes in Su(var)3-9 or Su(var)205 transcripts were detected in any of the cncC or 
dKeap1 mutants (Figure 5B).  Therefore, CncC and dKeap1 likely regulate heterochromatin 
formation at the post-transcriptional level. 
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Results of this study revealed a novel function of the Keap1-Nrf2 family proteins in the 
regulation of heterochromatin-induced gene silencing.  Interestingly, both dKeap1 and CncC 
depletions suppress PEV at pericentric heterochromatin (Figure 3, 4), indicating a cooperative 
role of dKeap1 and CncC in the regulation of 
heterochromatic silencing.  It has been well 
established that Keap1 acts as an inhibitor of 
Nrf2 in the transcription of 
antioxidant/detoxifying genes (Taguchi et al. 
2011).  Studies in Drosophila have confirmed 
that dKeap1 counteracts CncC in the 
regulation of lifespan and xenobiotic responses 
(Deng and Kerppola 2014; Sykiotis and 
Bohmann 2008).  On the other hand, we have 
revealed that dKeap1 can bind chromatin and 
activate ecdysone biosynthetic and response 
Figure 5. Regulation of heterochromatin level by CncC and dKeap1. A. Effects of cncC 
and dKeap1 null mutations on H3K9me2 heterochromatin marker.  Histone H3K9me2 and 
histone H3 (loading control) were detected in protein extractions from embryos with the 
genotypes labeled above using immunoblotting.  The levels of H3K9me2, represented by the 
intensity of the western bands, were measured and normalized to H3 levels.  The histogram 
shows the average fold of change of the H3K9me2 levels in cncK22 and dKeap1EY5 
homozygous embryos relative to those in heterozygous embryos.  Loss of CncC or dKeap1 
results in ~80% or ~40% decrease of H3K9me2 level, respectively.  The error bars indicate 
s.d. from three experiments using different biological replicates (*, P<0.05). B. Effects of 
CncC and dKeap1 depletions on transcripts.  RT-qPCR assays were used to measure 
transcript levels of the genes labeled below in the embryos of cncK22 and dKeap1EY5 null 
mutations (upper panels) or in the salivary glands that express shRNA targeting cncC or 
dKeap1 using Sgs3-GAL4 (lower panels).  The corresponding heterozygous embryos and 
salivary glands containing the GAL4 driver only were used as controls.  All transcript levels 
were normalized with the levels of Rp49 transcripts.  Histograms show the fold of change of 
transcript levels in the mutants relative to the transcript levels of the same gene in the 
controls.  Error bars represent the s.d. from two experiments using different biological 
replicates (*, P<0.05).  In all the mutants, cncC or dKeap1 transcripts were efficiently 
abolished, while the transcript levels of Su(var)3-9 and Su(var)205 (encoding HP1a) were not 
significantly altered. 
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genes in cooperation with CncC), and that dKeap1-CncC form complexes on chromatin and co-
activate Jheh and dKeap1 genes (Deng and Kerppola 2014).  The discovery that dKeap1 and 
CncC co-regulate heterochromatic silencing provides additional evidence in support of the model 
that the chromatin-bound dKeap1 cooperates with CncC when regulating chromatin structure and 
developmental genes, while the cytosolic dKeap1 inhibits CncC when controlling antioxidant and 
detoxifying genes (Figure 6).   
The current finding that sufficient dKeap1 and CncC proteins are required for the maintenance of 
heterochromatic silencing and the H3K9me2 heterochromatin marker contrasts with our previous 
hypothesis that dKeap1 and CncC facilitate euchromatin structure and transcriptional activation.  
Further studies are needed to determine the roles of dKeap1 and CncC in euchromatin 
architecture, especially at specific genomic loci such as ecdysone-induced puffs.  We now 
hypothesize that dKeap1 and CncC may regulate both euchromatin and heterochromatin, 
probably through interactions with different chromatin modifiers (Figure 6).  Such multiple 
functions in chromatin remodeling have been identified for some chromatin modifiers.  The 
essential heterochromatin component HP1a can occupy several euchromatic loci and activate 
transcription (Cryderman et al. 2005; Piacentini et al. 2003, 2009).  JIL-1, a histone H3S10 kinase 
that mainly occupies and maintains euchromatin regions, can also function in pericentric 
heterochromatin through the creation of H3S10phK9me2 mark and the interaction with Su(var)3-
9 (Boeke et al. 2010; Wang et al. 2014).  It will be interesting to elucidate whether dKeap1 and 
CncC directly interact with these chromatin modifiers.  It also remains to be determined whether 
mammalian Keap1-Nrf2 can regulate heterochromatic silencing similarly. 
Taken together, our study provides preliminary evidence in support of a novel function of the 
Keap1-Nrf2 oxidative/xenobiotic response factors in heterochromatin architecture.  Full 
characterization of the epigenetic functions of the Keap1/Nrf2 family proteins will help elucidate 
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the molecular mechanisms that mediate influences of environmental toxins on development and 
the epigenome, as well as the full range of roles of Keap1 and Nrf2 in human diseases.   
 
 
 
 
 
Materials and Methods 
Drosophila stocks 
All fly stocks were maintained using standard protocols.  Strains containing dKeap1036, 
dKeap1EY5, cncK22, UAS-dKeap1-RNAi, and UAS-cncC-RNAi were provided by Dirk Bohmann 
(Sykiotis and Bohmann 2008).  Strains containing cncK6, In(1)wm4, and 39C-5 were obtained from 
Osamu Shimmi, Kristen Johansen, and Lori Wallrath, respectively.  Salivary gland expression of 
RNAi was obtained using the Sgs3-GAL4 driver.  T(2:3)SbV and Sgs3-GAL4 were from the 
Bloomington Stock Center.  All studies were conducted at 25°C with the exception of larvae 
carrying the RNAi transgenes, which were maintained at 29°C to improve the efficiency of CncC 
and dKeap1 depletions.  All cncC and dKeap1 mutations were combined with TM6,Tb,Hu,e or 
Figure 6. Model for multiple dKeap1-CncC functions on chromatin. The dKeap1-CncC 
complex regulates different sets of genes using distinct mechanisms: dKeap1-CncC 
interactions in the cytoplasm or nucleoplasm suppress CncC activity and the activation of 
antioxidant/detoxifying genes (left).  In addition, dKeap1 can bind to chromatin and cooperate 
with CncC when regulating genes that are independent of stress-responses, such as 
developmental genes (middle, right), probably through a mechanism of epigenetic chromatin 
remodeling at least at some chromatic loci.  The potential function of dKeap1-CncC in 
heterochromatin architecture was supported by the current study (right). 
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TM6,Tb,Sb,Hu,e,Dfd-YFP balancers.  Appropriate progenies were selected based on the Hu 
marker in adults or Dfd-YFP fluorescence marker in embryos.  
PEV assays 
PEV assays were performed as previously described (Deng et al. 2010; Gandhi et al. 2015).  
Different mutations were introduced into In(1)wm4, T(2:3)SbV, or 39C-5 backgrounds using 
standard genetic crossing.  Newly eclosed adults were collected and aged for 4 days.  For wm4 
assays, the number of flies in each of 5 different classes were counted based on the percentage of 
red color in the compound eyes.  For SbV assays, the number of stubble bristles among 8 major 
scutellar bristles in each fly were counted, and the significance of the differences in average 
numbers was evaluated using the t-test.  Eyes and scutellar regions from representative 
individuals were photographed using an AmScope SM1-BX stereomicroscope with a digital 
camera.  
Immunoblotting 
Since the null mutations of cncC and dKeap1 are homozygous lethal at early 1st instar larval 
stage, late (12-16 hours) embryos were used for protein extraction and immunoblotting assays 
(Deng and Kerppola 2013).  Homozygous and heterozygous embryos were collected using apple 
juice plates and sorted based on the Dfd-YFP marker under a Leica MZ10 F fluorescence 
stereomicroscope.  Embryos (~15 in each sample) were homogenized in 50 μl of ice-cold Buffer 
(20 mM Tris-HCl pH8.0, 0.2% NP-40, 0.2% Triton X-100, 150 mM NaCl, 5 mM EDTA, 1 mM 
EGTA, 2 mM NaVO3, 1 mM PMSF, and 1.5 μg/ml aprotinin) and centrifuged at 10,000 g for 3 
minutes to remove precipitates.  The supernatant samples were resolved using a NuPAGE 4-12% 
Bis-Tris gel (Invitrogen).  The proteins were transferred to a nitrocellulose membrane (Bio-Rad) 
and probed using H3K9me2 mouse monoclonal antibody (1:400; Abcam) or H3 rabbit polyclonal 
antibody (1:3000; Proteintech), followed by HRP-conjugated secondary antibodies (1:3000, Bio-
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Rad).  Intensities of western bands were measured using ImageJ software.  The levels of 
H3K9me2 were calculated by normalizing the intensities of the H3K9me2 bands with those of the 
H3 bands.  Three replicates of this experiment were performed using independent biological 
samples.  Statistical tests were conducted using a one-way ANOVA. 
Transcript quantitation  
Around 50 late stage (12-16 hours) embryos that were collected using apple juice plates and 
sorted based on the Dfd-YFP marker or 10 pairs of salivary glands that were dissected from early 
wandering 3rd instar larvae were used for each mRNA extraction using the RNeasy kit (Qiagen).  
Isolated mRNA was quantified using a NanoDrop Spectrophotometer and the purity was 
evaluated based on A260/A280.  Next, mRNA was treated with RQ1 RNase-Free DNase 
(Promega) and reverse transcribed using the iScript™ cDNA Synthesis kit (Bio-Rad).  Real-time 
PCR was performed using the GoTaq qPCR kit (Bio-Rad) in an Eppendorf Mastercycler.  The 
relative transcript levels were calculated by assuming that they were proportional to 2-Cp, and 
normalized by the levels of Rp49 transcripts.  Two replicates using separate biological samples 
were performed and statistical tests were conducted using a one-way ANOVA.  Primer sequences 
producing intron-spanning amplicons were designed using Universal ProbeLibrary software 
(Roche) and are listed in Table S1.   
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Chapter 3: Loss of CncC and dKeap1 may reduce H3K9me2 levels on 
polytene chromosomes.  
Histone H3K9 dimethylation (H3K9me2) is prevalent in pericentromeric heterochromatin in 
Drosophila (Deng et al. 2010). Given the results from the PEV assay (i.e. CncC and dKeap1 
function as suppressors of variegation), I expected that knocking out CncC and/or dKeap1 would 
reduce the levels of H3K9me2. Before using a western blot to quantitatively measure H3K9me2 
levels, I used immunofluorescence staining to test whether the loss of CncC and/or dKeap1 would 
reduce the levels of H3K9me2. Since complete knockout of dKeap1 or CncC in Drosophila 
results in larval lethality, I used Mosaic Analysis with a Repressible Cell Marker (i.e. MARCM) 
to produce mosaic flies in which to study dKeap1 and CncC function (Wu and Luo 2006). The 
MARCM method produces flies that have some somatic cells with wild type dKeap1 and cncC 
and other cells with either dKeap1 or cncC (or both) null mutations. Here, I will describe the 
MARCM method for producing dKeap1 knockout mosaic flies. The MARCM method consists of 
several components. First, flies with the genotypes in Figure 7 were crossed. 
 
Figure 7. MARCM Cross. This cross was used to generate somatic mosaic flies in which to 
study dKeap1 function. Cells that express GFP have the KeapEY5 mutation. Abbreviations: hs = 
heat shock promoter, FLP = Flippase, FRT = Flippase Recombination Target Site, KeapEY5 – 
dKeap1 null mutation; for descriptions of UAS, GAL4, and GAL80 see Figure 8. This figure is 
modified from (Wu and Luo 2006). 
 
The F1 generation contains a heat shock (hs) induced promoter that induces the expression of 
flippase (FLP). After S phase, FLP facilitates a crossover between the two FRT sites (flippase 
recombination target sites), resulting in two chromosomes with tub-GAL80 (an inhibitor of tub-
 P 
 F1 
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GAL4) and FRT and two chromosomes with tub-GAL4, FRT, and KeapEY5 (Figure 9). (The UAS-
GAL4 expression system is described in Figure 8.) The chromosomes are divided between the two 
daughter cells such that both tub-GAL80 chromosomes end up in one cell and both KeapEY5 
chromosomes end up in the other cell. Since the cells with the KeapEY5 do not have tub-GAL80, 
tub-GAL4 is not inhibited so tub-GAL4 can induce the expression of the marker gene GFP. This 
produces a mosaic insect where half of the cells are Keap1 null (i.e. they have the KeapEY5 mutation) 
and are recognized by GFP expression and half of the cells express Keap1 but do not express GFP 
(i.e. because tub-GAL80 inhibits tub-GAL4 so it cannot induce the expression of GFP). 
 
 
Figure 8. UAS-GAL4 Expression System. (A) A tissue specific promoter is used to drive the 
expression of GAL4. GAL4 then binds to UAS and drives the expression of the gene of interest 
(GFP in this case). (B) When GAL80 is expressed, it inhibits the expression of GAL4. Thus, the 
UAS promoter is not activated and GFP is not expressed. Part A of this figure was modified from 
(Phelps and Brand 1998). 
20 
 
 
Figure 9. Mitotic generation of mosaic dKeap1 knockout flies. The cells in the flies produced 
from the cross in Figure 7 will undergo mitosis. During mitosis, FLP induces a crossover at the 
FRT sites. The cell then divides, and the chromosomes are divided between the two daughter 
cells. The daughter cell that does not express tub-GAL80 will be able to express tub-GAL4 
which, in turn, will lead to expression of GFP (green circle). In the other daughter cell (black 
circle), tub-GAL80 will inhibit tub-GAL4 and the cell will not express GFP. This figure is 
modified from (Wu and Luo 2006). 
 
Since the salivary glands cells stop mitotically dividing early in development, the F1 generation 
were heat-shocked as embryos. Once the flies reached 3rd instar, the salivary glands were dissected 
and probed with H3K9me2 mouse monoclonal antibody (1:200; Abcam, Cambridge, MA, USA) 
followed by a fluorescent goat anti-mouse secondary antibody (1:1000, ThermoFisher scientific, 
goat anti-mouse 594, A11032).  
Materials and Methods 
The fly stocks were all maintained according to standard protocols. The hs-FLP, UAS-GFP; tub-
GAL4, FRT82, tub-GAL80/TM6 stocks and the FRT82B, Keap1EY5/TM6 Tb Sb Hu e Dfd-YFP and 
the FRT82B, CncK22/TM6 Tb Sb Hu e Dfd-YFP stocks came from Dirk Bohmann’s lab. Virgin 
females from hs-FLP, UAS-GFP; tub-GAL4, FRT82, tub-GAL80/TM6 were crossed with males 
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from either FRT82B, Keap1EY5/TM6 Tb Sb Hu e Dfd-YFP or FRT82B, CncK22/TM6 Tb Sb Hu e Dfd-
YFP and the F1 embryos with the genotype hs-FLP, UAS-GFP/+; tub-GAL4, FRT82, tub-
GAL80/FRT82B, Keap1EY5 or hs-FLP, UAS-GFP/+; tub-GAL4, FRT82, tub-GAL80/FRT82B, 
CncK22 (identified by not having the Tb marker) were collected with apple juice plates and heat-
shocked at 37oC as 8-hour embryos for 30 minutes. The embryos were then allowed to develop to 
3rd instar larvae and then the salivary glands were dissected and fixed with para-formaldehyde 
(3.8% para-formaldehyde in 1X PBS and 1X Triton X-100) for 2 minutes and then washed in PBS-
0.2% Triton X-100. The salivary glands were then blocked with 1% NGS for 1 hour at room 
temperature, treated with H3K9me2 antibody (2.5 g/mL, ab1220, Abcam) at 4oC overnight, 
washed with 0.2% PBST and then treated with Alexa Fluor 594 goat anti-mouse secondary 
antibody (Invitrogen) for 2 hours at room temperature. The salivary glands were washed with 1X 
PBS, stained with Hoechst stain (1 g/mL, Hoechst 33342, Cell Signaling) for 10 minutes, and 
then mounted in 90% glycerol containing 
0.5% n-propyl gallate. The cells were 
visualized under a Zeiss LSM710 confocal 
microscope.   
Results and Discussion: If CncC and 
dKeap1 are involved in heterochromatin 
maintenance or formation, then knocking 
out either of these genes should result in 
more open chromatin (i.e. loss of 
heterochromatin), as represented by a 
reduction in heterochromatin markers (e.g. 
H3K9me2) at the pericentric regions of the 
polytene chromosomes. It was difficult to 
Figure 10: Knockout of cncC or dKeap1 
may reduce heterochromatin levels on 
polytene chromosomes. cncC and 
dKeap1 knockout cells (green; -/-) appear 
to have lower levels of H3K9me2 (pink) 
than wild type cells (+/+). 
22 
 
quantify the immunofluorescence intensity, but the null mutations cncCK6 and dKeap1EY5 visually 
appeared to result in minimal reduction of heterochromatin markers (Figure 10). There are a few 
potential reasons why there was not a greater reduction of H3K9me2. First, staining the salivary 
glands as whole mounts does not provide as clear levels of chromatin staining as would a 
chromosome squash. It is possible that the levels of H3K9me2 staining would have been more 
clearly reduced if a chromosome squash had been done, staining with anti-dKeap1 and/or anti-
CncC as well as heterochromatin markers and using as controls the chromosomes to which anti-
Keap1 and anti-CncC antibodies are bound. Second, the H3K9me2 levels may be tissue and 
developmental stage specific. The immunofluorescent experiment was done using salivary glands 
from 3rd instar larvae whereas the PEV assays and western blots were done using adult flies and 
late embryos, respectively. Finally, it is possible that the results from the dKeap1 knockout may 
have been partially masked by CncC overexpression (since dKeap1 would not be inhibiting it in 
the cytoplasm). Two approaches could be used to eliminate this problem. First, a dKeap1-ΔCTD 
mutant could be used instead of a dKeap1 knockout. The CTD domain is required for dKeap1 
binding to chromatin, but it is not necessary for CncC inhibition (dKeap1 binds to CncC via its 
Kelch domain). Thus, a dKeap1-ΔCTD mutant will still be able to inhibit CncC, but it will not be 
able to bind to the chromatin. A second approach that could be used is to knockout both dKeap1 
and CncC simultaneously via the MARCM method. This will eliminate the dKeap1-CncC complex 
and allow us to visualize the chromosomal effects of this complex. 
Future studies using the MARCM method 
The MARCM analysis is a powerful tool for investigating the effects of CncC and/or dKeap1 
knockout on chromatin structure because it not only allows us to (1) circumvent the early lethal 
phenotype of larvae, it also (2) allows the knockout cells and control cells to be compared directly 
in the same animal, thereby avoiding any unknown differences between larvae. Thus, the 
MARCM method will allow us to investigate the functions of CncC and dKeap1 in many 
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different programs in different tissues at different developmental stages. For example, MARCM 
will be used in future studies to (1) visualize the effects on chromatin structure when CncC and/or 
dKeap1 are knocked out and (2) observe binding loci of possible interacting partners in 
CncC/dKeap1 null and wild type cells. If chromatin modifiers are found that bind to the same loci 
as CncC and dKeap1, then bimolecular fluorescence complementation (BiFC) analysis and co-
immunoprecipitation experiments can be used to further test for any physical interaction. 
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Chapter 4: Conclusions and Future Directions 
This study supported the hypothesis that CncC and dKeap1 function cooperatively as suppressors 
of variegation at pericentromeric regions of chromosomes, likely acting at the post-transcriptional 
level. This was shown by three lines of evidence. First, results from PEV assays, using two 
separate reporter genes in two different genetic backgrounds with two different cncC and dKeap1 
mutations, indicated that CncC and dKeap1 function as suppressors of variegation (i.e. when 
cncC and/or dKeap1 are mutated, the chromatin in the region of the reporter gene is less tightly 
compacted) at the pericentromeric regions. Second, results from the western blots showed that 
reduction of CncC or dKeap1 leads to reduction of H3K9 dimethylation (H3K9me2; a 
pericentromeric heterochromatin marker). Finally, the RT-qPCR results showed that there was no 
significant change in the expression levels of Su(var)3-9 and Su(var)205, which encode Su(var)3-
9 and HP1 – two essential proteins for heterochromatin formation. This indicates that CncC and 
dKeap1 are probably not regulating heterochromatin by regulating the transcription of 
heterochromatin promoting genes, but rather, are regulating heterochromatin at the post-
transcriptional level.  
Future studies on the regulation of heterochromatin by CncC and dKeap1 
The mechanism by which CncC and dKeap1 regulate chromatin structure remains unknown. To 
elucidate the mechanism by which CncC and dKeap1 regulate pericentromeric heterochromatin, 
an initial step is to identify chromatin modifiers that CncC and/or dKeap1 interact with. 
Pericentromeric heterochromatin is established by the HP1/SU(VAR)3-9 complex. In the classic 
model, SU(VAR)3-9 methylates the chromatin at histone H3K9 (Demakova et al. 2007) and then 
HP1 binds to the methylated lysine residue and maintains heterochromatin structure (Zeng, Ball, 
and Yokomori 2010). Given the central role of the HP1/SU(VAR)3-9 complex in 
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heterochromatin establishment and maintenance, these proteins are reasonable candidate 
interaction partners of CncC and dKeap1. 
Future studies investigating whether CncC and dKeap1 in regulate euchromatin 
It is likely that CncC and dKeap1 also regulate euchromatin structure. CncC and dKeap1 are both 
known to bind to chromosomal puff regions (i.e. decondensed chromatin where transcription can 
occur) (Deng and Kerppola 2013). CncC overexpression results in a more open chromatin 
structure at the telomeres. Somatic knockout of dKeap1 via MARCM results in salivary gland 
knockout cells with more condensed polytene chromosomes compared to control cells. Larvae 
with the dKeap1-ΔCTD truncation (which prevents dKeap1 from binding to chromatin) had more 
condensed polytene chromosome arms. Thus, in the future, the roles of CncC and dKeap1 in 
regulating euchromatin structure should be investigated. Two initial experiments to test this 
would be generating somatic knockouts of dKeap1 and CncC and then measuring the levels of (1) 
heterochromatin markers, such as H3K27me3 and HP1, and (2) euchromatin markers, such as 
H3K4me3 and H3K9ac). 
Broader impacts 
Investigating the complex roles of Nrf2/CncC and Keap1/dKeap1 in development and xenobiotic 
response can have several implications. First, understanding the roles of Nrf2 and CncC can lead 
to a better understanding of how epigenetic status is affected by the environment. Several studies 
have found correlations between exposure to toxins (xenobiotics or oxidative stress) and epigenetic 
modification. Some of these environmental factors directly impact Nrf2 interaction with Keap1. 
Other environmental factors can epigenetically regulate Nrf2 expression (Kang and Hyun 2017). 
Still others, may act via Nrf2 to alter the epigenetic status of specific chromatin regions. 
Understanding how environmental factors can affect epigenetic status could help us predict the 
effects of these factors on the health of humans and other animals. Second, it can lead to a better 
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understanding of how drugs other xenobiotic factors affect development. For example, 
phenobarbital has two effects in Drosophila larval salivary glands. (1) Phenobarbital disrupts the 
interaction between dKeap1 and CncC in the cytoplasm, releasing CncC to bind to, and activate 
expression of, xenobiotic response genes. (2) Phenobarbital also induces dKeap1 and CncC to act 
cooperatively to increase expression of dKeap1 and juvenile hormone epoxide hydrolase (Jheh) 
genes. Since JHEH proteins degrade juvenile hormone and promote metamorphosis (Deng and 
Kerppola 2014), phenobarbital may disrupt developmental timing in Drosophila. Understanding 
how drugs affect development, could help us predict physiological effects before drugs are used. 
Finally, understanding the interaction between the xenobiotic response and developmental 
pathways can help us understand the complex role of Nrf2/Keap1 in human disease. For example, 
Nrf2 knockout has been associated with cancer and several neurological diseases (e.g. Alzheimer’s 
disease and Parkinson’s disease). However, Nrf2 knockdown and Nrf2 overexpresion can both lead 
to tumorigenesis. One possible reason for this is that when Nrf2 is knocked down, the animal is 
more susceptible to carcinogens (since Nrf2 cannot activate xenobiotic response genes), but when 
Nrf2 is overexpressed it activates xenobiotic response genes which hinder cancer treatments by 
inhibiting anti-cancer drugs (Taguchi et al. 2011). Understanding the roles of Nrf2 and Keap1 could 
lead to the development of therapies that target Nrf2 and/or Keap1 in the treatments of diseases and 
developmental disorders. 
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